<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02265029</url>
  </required_header>
  <id_info>
    <org_study_id>DCIC/13/68</org_study_id>
    <nct_id>NCT02265029</nct_id>
  </id_info>
  <brief_title>Evaluation of Spa Therapy in the Treatment of Fibromyalgia</brief_title>
  <acronym>THERMALGI</acronym>
  <official_title>Evaluation of Spa Therapy in the Treatment of Fibromyalgia : a Randomized, Controlled, Open Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association Francaise pour la Recherche Thermale</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Floralis</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Association Francaise pour la Recherche Thermale</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fibromyalgia is a common health problem that causes widespread pain and tenderness (sensitive
      to touch). The pain and tenderness tend to come and go, and move about the body. There is no
      cure for fibromyalgia. Complementary and alternative therapy such as acupuncture,
      chiropractic and massage therapy, can be useful to manage fibromyalgia symptoms. Many of
      these treatments have not been well tested in patients with fibromyalgia. Fibromyalgia affect
      3 to 4% of the general population and 14 % of patients with rheumatologic disease.
      Fibromyalgia is most common in women 90 % in many studies. It most often starts in middle
      adulthood. A chronic evolution occured for Fibromyalgic patients with a major alteration of
      quality of life.

      Thermalgi is a randomized, multicentre, open label trial wich aims to evaluate the effects of
      spa therapy in rheumatologia on evolution of disability in daily life of patients with
      fibromyalgia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      THERMALGI is a controlled, randomized, multicentre, open label trial wich aims to evaluate
      the effects of spa therapy in rheumatologia on evolution of disability in daily life of
      patients with fibromyalgia.

      Patients with fibromyalgia (American College of Rheumatology Criteria) and a FIQ score
      (Fibromyalgia Impact Questionnaire) &gt; 39 will be randomized.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Actual">September 11, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Handicap in everyday life</measure>
    <time_frame>6 months</time_frame>
    <description>Decrease of 14% (success rate) of FIQ questionnaire at 6 months compare to baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>at baseline, 3, 6, 9 and 12 months</time_frame>
    <description>Comparison of the FIQ questionnaire mean between baseline, 3 and 6 months. Quantitative evaluation of the primary outcome.
EUROQUOL (EQ5D) score evolution between baseline, 6 and 12 months.
Evolution of PGA (autoevaluation) (Patient Global Assessment) and IGA (hetero evaluation) (Investigator's Global Assessment) scores between baseline, 3, 6, 9 and 12 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain evolution</measure>
    <time_frame>at baseline, 3, 6, 9 and 12 months</time_frame>
    <description>Monthly evolution of VAS (Visual Analogic Scale) pain and PCS questionnaire (Pain Catastrophizing Scale) between baseline, 3, 6, 9 and 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep quality</measure>
    <time_frame>at baseline, 3, 6, 9 and 12 months</time_frame>
    <description>Evolution of PSQI questionnaire (Pittsburg Sleep Quality Index) and Epworth Scale (ESS) (Epworth Sleepiness Scale) between baseline, 3, 6, 9 and 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>at baseline, 3, 6, 9 and 12 months</time_frame>
    <description>Evolution of Pichot questionnaire between baseline, 3, 6, 9 and 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>at baseline, 3, 6, 9 and 12 months</time_frame>
    <description>Evolution of HADS (Hospital Anxiety Depression Scale) and Coping-Etat questionnaires between baseline, 3, 6, 9 and 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>at baseline, 3, 6, 9 and 12 months</time_frame>
    <description>Evolution of Baecke score between baseline, 6 and 12 months
evolution of BMI (Bone Mass Index) between baseline, 3, 6, 9 and 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medico economic impact</measure>
    <time_frame>at baseline, 3, 6, 9 and 12 months</time_frame>
    <description>Drugs consumption, medical and paramedical consultations, hospitalisations, professional absenteeism, complementary medicines resort.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Objective physical activity</measure>
    <time_frame>at baseline, 3, and 6 months</time_frame>
    <description>Record of day activity during one week with actigraphy at baseline, 3 and 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Objective sleep quality</measure>
    <time_frame>at baseline, 3, and 6 months</time_frame>
    <description>Record of night activity and cardiac variability at baseline, 3 and 6 months</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">220</enrollment>
  <condition>Fibromyalgia</condition>
  <condition>Rheumatism, Muscular</condition>
  <arm_group>
    <arm_group_label>Immediate spa treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spa treatment during 18 days soon after randomization : the most adapted to the concerned pathology and common to all of spa resorts (whirpool bath with automatic air and water massage cycles, massaging shower,...)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late SPA treatment</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Spa treatment during 18 days soon after 6 months visit : the most adapted to the concerned pathology and common to all of spa resorts (whirpool bath with automatic air and water massage cycles, massaging shower,...)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Immediate spa treatment</intervention_name>
    <description>spa treatment in rheumatology with sedative and antalgique techniques and mobilizing techniques (rehabilitation in pool)</description>
    <arm_group_label>Immediate spa treatment</arm_group_label>
    <other_name>Spa treatment soon after randomisation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Late spa treatment</intervention_name>
    <description>spa treatment in rheumatology with sedative and antalgique techniques and mobilizing techniques (rehabilitation in pool)</description>
    <arm_group_label>Late SPA treatment</arm_group_label>
    <other_name>Spa treatment after 6 months visit in the study</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  both sexes, more than 18 years old patients

          -  available for a spa treatment in rheumatology during 18 days (immediate or late spa)
             and a follow-up period of 12 months

          -  with fibromyalgia ( ACR criteria 2010) for at least 1 year and with a stable treatment
             for at least 3 months

          -  with a FIQ score &gt; or = 39 (fibromyalgia moderate to severe)

          -  voluntary to participate to the study, informed consent form signed after appropriate
             information

          -  affiliation to the social security system or equivalent

        Exclusion Criteria:

          -  contra-indication of spa treatment (cancer in progress, psychiatrics disorders,
             immunodeficiency)

          -  no previous spa treatment in rheumatology within 1 year prior to inclusion

          -  substantial variation of the therapeutic coverage in the previous 3 months the
             inclusion (change of medicinal class, starting up of a réentrainement in the effort or
             a cognitivio-behavioral technique)

          -  subject with an other chronic severe disease (severe asthma, severe cardiac
             insuffisiancy, respiratory, renal or liver failures, evolutive rheumatic disease,
             inflammatory colitis...)

          -  subject participating to an other clinical study inerventionnal

          -  pregnancy, parturient or breast feeding

          -  no psychiatric illness or social situation that would preclude study compliance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Caroline MAINDET DOMINICI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital University Grenoble</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>station thermale AIX LES BAINS</name>
      <address>
        <city>Aix les Bains</city>
        <zip>73100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>station thermale ALLEVARD LES BAINS</name>
      <address>
        <city>Allevard</city>
        <zip>38580</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>station thermale BOURBON LANCY</name>
      <address>
        <city>Bourbon-Lancy</city>
        <zip>71140</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>station thermale LAMALOU LES BAINS</name>
      <address>
        <city>Lamalou les Bains</city>
        <zip>34240</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Station thermale URIAGE LES BAINS</name>
      <address>
        <city>Uriage les bains</city>
        <zip>38410</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Adler GK, Kinsley BT, Hurwitz S, Mossey CJ, Goldenberg DL. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med. 1999 May;106(5):534-43.</citation>
    <PMID>10335725</PMID>
  </reference>
  <reference>
    <citation>Altan L, Bingöl U, Aykaç M, Koç Z, Yurtkuran M. Investigation of the effects of pool-based exercise on fibromyalgia syndrome. Rheumatol Int. 2004 Sep;24(5):272-7. Epub 2003 Sep 24.</citation>
    <PMID>14508601</PMID>
  </reference>
  <reference>
    <citation>Arnold LM, Clauw DJ, Wohlreich MM, Wang F, Ahl J, Gaynor PJ, Chappell AS. Efficacy of duloxetine in patients with fibromyalgia: pooled analysis of 4 placebo-controlled clinical trials. Prim Care Companion J Clin Psychiatry. 2009;11(5):237-44. doi: 10.4088/PCC.08m00680.</citation>
    <PMID>19956462</PMID>
  </reference>
  <reference>
    <citation>Baranowsky J, Klose P, Musial F, Häuser W, Dobos G, Langhorst J. Qualitative systemic review of randomized controlled trials on complementary and alternative medicine treatments in fibromyalgia. Rheumatol Int. 2009 Nov;30(1):1-21. doi: 10.1007/s00296-009-0977-5. Epub 2009 Aug 12. Review. Erratum in: Rheumatol Int. 2009 Nov;30(1):23. Rheumatol Int. 2009 Nov;30(1):23. Haeuser, Winfried [corrected to Häuser, Winfried]..</citation>
    <PMID>19672601</PMID>
  </reference>
  <reference>
    <citation>Bellometti S, Galzigna L. Function of the hypothalamic adrenal axis in patients with fibromyalgia syndrome undergoing mud-pack treatment. Int J Clin Pharmacol Res. 1999;19(1):27-33.</citation>
    <PMID>10450540</PMID>
  </reference>
  <reference>
    <citation>Bennett RM, Bushmakin AG, Cappelleri JC, Zlateva G, Sadosky AB. Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol. 2009 Jun;36(6):1304-11. doi: 10.3899/jrheum.081090. Epub 2009 Apr 15.</citation>
    <PMID>19369473</PMID>
  </reference>
  <reference>
    <citation>Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med. 2003 May;114(7):537-45.</citation>
    <PMID>12753877</PMID>
  </reference>
  <reference>
    <citation>Biasi G, Manca S, Manganelli S, Marcolongo R. Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res. 1998;18(1):13-9.</citation>
    <PMID>9604730</PMID>
  </reference>
  <reference>
    <citation>Bircan C, Karasel SA, Akgün B, El O, Alper S. Effects of muscle strengthening versus aerobic exercise program in fibromyalgia. Rheumatol Int. 2008 Apr;28(6):527-32. Epub 2007 Nov 3.</citation>
    <PMID>17982749</PMID>
  </reference>
  <reference>
    <citation>Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, Saraiva F, Nacci F, Thomas E, Caubère JP, Le Lay K, Taieb C, Matucci-Cerinic M. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum. 2010 Jun;39(6):448-53. doi: 10.1016/j.semarthrit.2008.12.003. Epub 2009 Feb 27.</citation>
    <PMID>19250656</PMID>
  </reference>
  <reference>
    <citation>Burckhardt CS, Mannerkorpi K, Hedenberg L, Bjelle A. A randomized, controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol. 1994 Apr;21(4):714-20.</citation>
    <PMID>8035399</PMID>
  </reference>
  <reference>
    <citation>Burckhardt CS. Multidisciplinary approaches for management of fibromyalgia. Curr Pharm Des. 2006;12(1):59-66. Review.</citation>
    <PMID>16454725</PMID>
  </reference>
  <reference>
    <citation>Busch AJ, Schachter CL, Overend TJ, Peloso PM, Barber KA. Exercise for fibromyalgia: a systematic review. J Rheumatol. 2008 Jun;35(6):1130-44. Epub 2008 May 1. Review.</citation>
    <PMID>18464301</PMID>
  </reference>
  <reference>
    <citation>Busch AJ, Barber KA, Overend TJ, Peloso PM, Schachter CL. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003786. Review.</citation>
    <PMID>17943797</PMID>
  </reference>
  <reference>
    <citation>Buskila D, Neumann L, Vaisberg G, Alkalay D, Wolfe F. Increased rates of fibromyalgia following cervical spine injury. A controlled study of 161 cases of traumatic injury. Arthritis Rheum. 1997 Mar;40(3):446-52.</citation>
    <PMID>9082932</PMID>
  </reference>
  <reference>
    <citation>Carville SF, Arendt-Nielsen L, Bliddal H, Blotman F, Branco JC, Buskila D, Da Silva JA, Danneskiold-Samsøe B, Dincer F, Henriksson C, Henriksson KG, Kosek E, Longley K, McCarthy GM, Perrot S, Puszczewicz M, Sarzi-Puttini P, Silman A, Späth M, Choy EH; EULAR. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008 Apr;67(4):536-41. Epub 2007 Jul 20. Review. Erratum in: Ann Rheum Dis. 2015 Feb;74(2):476. Arendt-Nielsen, S [corrected to Arendt-Nielsen, L].</citation>
    <PMID>17644548</PMID>
  </reference>
  <reference>
    <citation>Cedraschi C, Desmeules J, Rapiti E, Baumgartner E, Cohen P, Finckh A, Allaz AF, Vischer TL. Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management. Ann Rheum Dis. 2004 Mar;63(3):290-6.</citation>
    <PMID>14962965</PMID>
  </reference>
  <reference>
    <citation>Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, Young JP Jr, LaMoreaux LK, Martin SA, Sharma U; Pregabalin 1008-105 Study Group. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005 Apr;52(4):1264-73.</citation>
    <PMID>15818684</PMID>
  </reference>
  <reference>
    <citation>Dauvilliers Y, Touchon J. [Sleep in fibromyalgia: review of clinical and polysomnographic data]. Neurophysiol Clin. 2001 Feb;31(1):18-33. Review. French.</citation>
    <PMID>11281066</PMID>
  </reference>
  <reference>
    <citation>Evcik D, Kizilay B, Gökçen E. The effects of balneotherapy on fibromyalgia patients. Rheumatol Int. 2002 Jun;22(2):56-9. Epub 2002 Mar 29.</citation>
    <PMID>12070676</PMID>
  </reference>
  <reference>
    <citation>Dönmez A, Karagülle MZ, Tercan N, Dinler M, Işsever H, Karagülle M, Turan M. SPA therapy in fibromyalgia: a randomised controlled clinic study. Rheumatol Int. 2005 Dec;26(2):168-72. Epub 2005 Jun 17.</citation>
    <PMID>15965635</PMID>
  </reference>
  <reference>
    <citation>Fioravanti A, Perpignano G, Tirri G, Cardinale G, Gianniti C, Lanza CE, Loi A, Tirri E, Sfriso P, Cozzi F. Effects of mud-bath treatment on fibromyalgia patients: a randomized clinical trial. Rheumatol Int. 2007 Oct;27(12):1157-61. Epub 2007 May 23.</citation>
    <PMID>17520260</PMID>
  </reference>
  <reference>
    <citation>Forestier R, Desfour H, Tessier JM, Françon A, Foote AM, Genty C, Rolland C, Roques CF, Bosson JL. Spa therapy in the treatment of knee osteoarthritis: a large randomised multicentre trial. Ann Rheum Dis. 2010 Apr;69(4):660-5. doi: 10.1136/ard.2009.113209. Epub 2009 Sep 3.</citation>
    <PMID>19734131</PMID>
  </reference>
  <reference>
    <citation>Furlan R, Colombo S, Perego F, Atzeni F, Diana A, Barbic F, Porta A, Pace F, Malliani A, Sarzi-Puttini P. Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgia. J Rheumatol. 2005 Sep;32(9):1787-93.</citation>
    <PMID>16142879</PMID>
  </reference>
  <reference>
    <citation>Giske L, Vøllestad NK, Mengshoel AM, Jensen J, Knardahl S, Røe C. Attenuated adrenergic responses to exercise in women with fibromyalgia--a controlled study. Eur J Pain. 2008 Apr;12(3):351-60. Epub 2007 Sep 10.</citation>
    <PMID>17827042</PMID>
  </reference>
  <reference>
    <citation>Guétin S, Giniès P, Siou DK, Picot MC, Pommié C, Guldner E, Gosp AM, Ostyn K, Coudeyre E, Touchon J. The effects of music intervention in the management of chronic pain: a single-blind, randomized, controlled trial. Clin J Pain. 2012 May;28(4):329-37. doi: 10.1097/AJP.0b013e31822be973.</citation>
    <PMID>22001666</PMID>
  </reference>
  <reference>
    <citation>Hassett AL, Radvanski DC, Vaschillo EG, Vaschillo B, Sigal LH, Karavidas MK, Buyske S, Lehrer PM. A pilot study of the efficacy of heart rate variability (HRV) biofeedback in patients with fibromyalgia. Appl Psychophysiol Biofeedback. 2007 Mar;32(1):1-10. Epub 2007 Jan 12.</citation>
    <PMID>17219062</PMID>
  </reference>
  <reference>
    <citation>Jentoft ES, Kvalvik AG, Mengshoel AM. Effects of pool-based and land-based aerobic exercise on women with fibromyalgia/chronic widespread muscle pain. Arthritis Rheum. 2001 Feb;45(1):42-7.</citation>
    <PMID>11308060</PMID>
  </reference>
  <reference>
    <citation>Kazlauskaite R, Evans AT, Villabona CV, Abdu TA, Ambrosi B, Atkinson AB, Choi CH, Clayton RN, Courtney CH, Gonc EN, Maghnie M, Rose SR, Soule SG, Tordjman K; Consortium for Evaluation of Corticotropin Test in Hypothalamic-Pituitary Adrenal Insufficiency. Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis. J Clin Endocrinol Metab. 2008 Nov;93(11):4245-53. doi: 10.1210/jc.2008-0710. Epub 2008 Aug 12.</citation>
    <PMID>18697868</PMID>
  </reference>
  <reference>
    <citation>Kirschbaum C, Hellhammer DH. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology. 1994;19(4):313-33. Review.</citation>
    <PMID>8047637</PMID>
  </reference>
  <reference>
    <citation>Ledingham J, Doherty S, Doherty M. Primary fibromyalgia syndrome--an outcome study. Br J Rheumatol. 1993 Feb;32(2):139-42.</citation>
    <PMID>8428227</PMID>
  </reference>
  <reference>
    <citation>Lerma C, Martinez A, Ruiz N, Vargas A, Infante O, Martinez-Lavin M. Nocturnal heart rate variability parameters as potential fibromyalgia biomarker: correlation with symptoms severity. Arthritis Res Ther. 2011;13(6):R185. doi: 10.1186/ar3513. Epub 2011 Nov 16.</citation>
    <PMID>22087605</PMID>
  </reference>
  <reference>
    <citation>McCain GA, Bell DA, Mai FM, Halliday PD. A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis Rheum. 1988 Sep;31(9):1135-41.</citation>
    <PMID>3048273</PMID>
  </reference>
  <reference>
    <citation>McCracken LM, MacKichan F, Eccleston C. Contextual cognitive-behavioral therapy for severely disabled chronic pain sufferers: effectiveness and clinically significant change. Eur J Pain. 2007 Apr;11(3):314-22. Epub 2006 Jun 9.</citation>
    <PMID>16762571</PMID>
  </reference>
  <reference>
    <citation>McVeigh JG, McGaughey H, Hall M, Kane P. The effectiveness of hydrotherapy in the management of fibromyalgia syndrome: a systematic review. Rheumatol Int. 2008 Dec;29(2):119-30. doi: 10.1007/s00296-008-0674-9. Epub 2008 Aug 27. Review.</citation>
    <PMID>18751709</PMID>
  </reference>
  <reference>
    <citation>Moldofsky H, Inhaber NH, Guinta DR, Alvarez-Horine SB. Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study. J Rheumatol. 2010 Oct;37(10):2156-66. doi: 10.3899/jrheum.091041. Epub 2010 Aug 3.</citation>
    <PMID>20682669</PMID>
  </reference>
  <reference>
    <citation>Moldofsky H, Lue FA, Mously C, Roth-Schechter B, Reynolds WJ. The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study. J Rheumatol. 1996 Mar;23(3):529-33.</citation>
    <PMID>8832997</PMID>
  </reference>
  <reference>
    <citation>Morley S, Williams AC. RCTs of psychological treatments for chronic pain: progress and challenges. Pain. 2006 Apr;121(3):171-2. Epub 2006 Mar 2.</citation>
    <PMID>16513271</PMID>
  </reference>
  <reference>
    <citation>Mostoufi SM, Afari N, Ahumada SM, Reis V, Wetherell JL. Health and distress predictors of heart rate variability in fibromyalgia and other forms of chronic pain. J Psychosom Res. 2012 Jan;72(1):39-44. doi: 10.1016/j.jpsychores.2011.05.007. Epub 2011 Jun 30.</citation>
    <PMID>22200521</PMID>
  </reference>
  <reference>
    <citation>Nater UM, Rohleder N. Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research. Psychoneuroendocrinology. 2009 May;34(4):486-96. doi: 10.1016/j.psyneuen.2009.01.014. Epub 2009 Feb 26. Review.</citation>
    <PMID>19249160</PMID>
  </reference>
  <reference>
    <citation>Onieva-Zafra MD, Castro-Sánchez AM, Matarán-Peñarrocha GA, Moreno-Lorenzo C. Effect of music as nursing intervention for people diagnosed with fibromyalgia. Pain Manag Nurs. 2013 Jun;14(2):e39-46. doi: 10.1016/j.pmn.2010.09.004. Epub 2010 Nov 26.</citation>
    <PMID>23108015</PMID>
  </reference>
  <reference>
    <citation>Ozkurt S, Dönmez A, Zeki Karagülle M, Uzunoğlu E, Turan M, Erdoğan N. Balneotherapy in fibromyalgia: a single blind randomized controlled clinical study. Rheumatol Int. 2012 Jul;32(7):1949-54. doi: 10.1007/s00296-011-1888-9. Epub 2011 Apr 2.</citation>
    <PMID>21461716</PMID>
  </reference>
  <reference>
    <citation>Pioro-Boisset M, Esdaile JM, Fitzcharles MA. Alternative medicine use in fibromyalgia syndrome. Arthritis Care Res. 1996 Feb;9(1):13-7.</citation>
    <PMID>8945108</PMID>
  </reference>
  <reference>
    <citation>Richards SC, Scott DL. Prescribed exercise in people with fibromyalgia: parallel group randomised controlled trial. BMJ. 2002 Jul 27;325(7357):185.</citation>
    <PMID>12142304</PMID>
  </reference>
  <reference>
    <citation>Russell IJ, Kamin M, Bennett RM, Schnitzer TJ, Green JA, Katz WA. Efficacy of tramadol in treatment of pain in fibromyalgia. J Clin Rheumatol. 2000 Oct;6(5):250-7.</citation>
    <PMID>19078481</PMID>
  </reference>
  <reference>
    <citation>Sayar K, Aksu G, Ak I, Tosun M. Venlafaxine treatment of fibromyalgia. Ann Pharmacother. 2003 Nov;37(11):1561-5.</citation>
    <PMID>14565792</PMID>
  </reference>
  <reference>
    <citation>Sephton SE, Salmon P, Weissbecker I, Ulmer C, Floyd A, Hoover K, Studts JL. Mindfulness meditation alleviates depressive symptoms in women with fibromyalgia: results of a randomized clinical trial. Arthritis Rheum. 2007 Feb 15;57(1):77-85.</citation>
    <PMID>17266067</PMID>
  </reference>
  <reference>
    <citation>Tomas-Carus P, Häkkinen A, Gusi N, Leal A, Häkkinen K, Ortega-Alonso A. Aquatic training and detraining on fitness and quality of life in fibromyalgia. Med Sci Sports Exerc. 2007 Jul;39(7):1044-50.</citation>
    <PMID>17596770</PMID>
  </reference>
  <reference>
    <citation>van Koulil S, Effting M, Kraaimaat FW, van Lankveld W, van Helmond T, Cats H, van Riel PL, de Jong AJ, Haverman JF, Evers AW. Cognitive-behavioural therapies and exercise programmes for patients with fibromyalgia: state of the art and future directions. Ann Rheum Dis. 2007 May;66(5):571-81. Epub 2006 Aug 17. Review.</citation>
    <PMID>16916856</PMID>
  </reference>
  <reference>
    <citation>Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990 Feb;33(2):160-72.</citation>
    <PMID>2306288</PMID>
  </reference>
  <reference>
    <citation>Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010 May;62(5):600-10. doi: 10.1002/acr.20140.</citation>
    <PMID>20461783</PMID>
  </reference>
  <reference>
    <citation>Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum. 2008 Jun;37(6):339-52. doi: 10.1016/j.semarthrit.2007.09.003. Epub 2008 Jan 14.</citation>
    <PMID>18191990</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 9, 2014</study_first_submitted>
  <study_first_submitted_qc>October 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2014</study_first_posted>
  <last_update_submitted>September 21, 2017</last_update_submitted>
  <last_update_submitted_qc>September 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>fibromyalgia</keyword>
  <keyword>rheumatism</keyword>
  <keyword>fatigue syndrom</keyword>
  <keyword>pain</keyword>
  <keyword>spa treatment in rheumatology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
    <mesh_term>Rheumatic Diseases</mesh_term>
    <mesh_term>Collagen Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

